Neurimmune: Promising Phase 1 Results for Antibody NI006 in ATTR Cardiomyopathy Published in the New
Results also presented during late-breaking session at ESC Heart Failure congress 2023 ZURICH, May 20, 2023 (Newswire.com) - Neurimmune announced today that primary results of its Phase 1 proof-of-concept stud...
Source: pharmiweb.com